Safety and efficacy of turoctocog alfa (NovoEight ® ) during surgery in patients with haemophilia A: results from the multinational guardian ™ clinical trials-Reference-Cited by-同舟云学术

Safety and efficacy of turoctocog alfa (NovoEight ® ) during surgery in patients with haemophilia A: results from the multinational guardian ™ clinical trials

Published:2014-10-02 Issue:1 Volume:21 Page:34-40
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Santagostino E.¹,Lentz S. R.²,Misgav M.³,Brand B.⁴,Chowdary P.⁵,Savic A.⁶,Kilinc Y.⁷,Amit Y.⁸,Amendola A.⁹,Solimeno L. P.¹⁰,Saugstrup T.¹¹,Matytsina I.¹²

Affiliation:

1. Angelo Bianchi Bonomi Hemophilia and Thrombosis Center IRCCS Ca' Granda Foundation, Maggiore Hospital Policlinico Milan Italy

2. Department of Internal Medicine The University of Iowa Carver College of Medicine Iowa City IA USA

3. National Hemophilia Center Chaim Sheba Medical Center affiliated to the Sackler School of Medicine Tel Aviv University Tel Aviv Israel

4. Division of Hematology University Hospital Zurich Switzerland

5. Katharine Dormandy Haemophilia Centre and Thrombosis Unit Royal Free Hospital London UK

6. Clinic of Hematology Clinical Center of Vojvodina, Faculty of Medicine University of Novi Sad Novi Sad Serbia

7. Department of Pediatric Hematology Cukurova University Adana Turkey

8. Israel National Hemophilia Center Tel Hashomer Hospital Israel

9. Department of Orthopaedics and Rehabilitation University of Iowa Iowa City IA USA

10. Haemophilic Arthropathy Treatment Centre ‘M.G. Gatti Randi’, CTO Hospital Milan Italy

11. Biostatistics Haemophilia Novo Nordisk A/S Soeborg Denmark

12. Medical & Science Haemophilia Novo Nordisk A/S Soeborg Denmark

Funder

Novo Nordisk A/S

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.12518

Reference14 articles.

1. Surgical management of advanced hemophilic arthropathy. An overview of 20 years' experience;Luck JV;Clin Orthop Relat Res,1989

2. Seventy-two total knee arthroplasties performed in patients with haemophilia using continuous infusion

3. Surgery in Hemophilia. The General View: Patient Selection, Timing, and Preoperative Assessment

4. Purification and characterization of a new recombinant factor VIII (N8)

5. Functional characteristics of N8, a new recombinant FVIII

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minor surgical procedures during immune tolerance induction in people with hemophilia A and inhibitors: results from the Brazilian Immune Tolerance (BrazIT) study cohort;Hematology, Transfusion and Cell Therapy;2024-09

2. Final Analysis Results from the AGEHA Study: Emicizumab Prophylaxis for Acquired Hemophilia A with or without Immunosuppressive Therapy;Thrombosis and Haemostasis;2024-08-12

3. Real-world long-term safety and effectiveness of turoctocog alfa in the treatment of haemophilia A in Japan: results from a multicentre, non-interventional, post-marketing study;Hematology;2024-02-20

4. Surgical Experience from the STASEY Study of Emicizumab Prophylaxis in People with Hemophilia A with Factor VIII Inhibitors;TH Open;2024-01

5. Non-viral and viral delivery systems for hemophilia A therapy: recent development and prospects;Annals of Hematology;2023-11-11